Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINR: Ixazomib Combinations in NFKB2-Rearranged Multiple Myeloma
NCT02765854Phase 2Completed
- Sponsor
- Emory University
- Start
- Sep 2016
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by Emory University. Started Sep 2016; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02765854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765854.